19.09.2018
- Recently, the pharmaceutical contract development and manufacturing organization (CDMO) industry has been extremely active in M&A, as is the pharma and generics industry itself...
19.09.2018
- With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service...
Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active...
01.06.2016
- Swiss-based pharmaceutical process development and active pharmaceutical ingredient (API) manufacturer, Carbogen Amcis, has announced plans to extend its operations in Bubendorf...
08.08.2014
- Carbogen Amcis, Swiss-based pharmaceutical process development and active pharmaceutical ingredient (API) manufacturer, has announced plans to take over operations of a high...
26.10.2011
- With more and more players in big pharma looking to outsource in order to focus on core competencies, custom manufacturers stand to benefit from this shift. The most exciting trend...
13.07.2011
- Switzerland-based Carbogen Amcis, a pharmaceutical process development and API manufacturing company, announced that Mark C. Griffiths has been named chief executive officer...
24.02.2011
- Swiss Carbogen Amcis, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has advised its employees and the authorities today of...
